Quantbot Technologies LP boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 219.5% during the fourth ...
Amgen (NASDAQ:AMGN – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Saturday. A number of other research ...
Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...
Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...
Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'
A federal judge on Friday dismissed Amgen’s lawsuit against Colorado's drug affordability board and its decision to place a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback